SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-18-008948
Filing Date
2018-02-13
Accepted
2018-02-13 14:46:09
Documents
1
Group Members
AMIR L. ECKERCAROL G. FRANKENFIELD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5901_1sc13ga.htm SC 13G/A 114647
  Complete submission text file 0001104659-18-008948.txt   116345
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Subject) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86512 | Film No.: 18602475
SIC: 2834 Pharmaceutical Preparations

Mailing Address 555 E. LANCASTER AVE SUITE 540 RADNOR PA 19087
Business Address 555 E. LANCASTER AVE SUITE 540 RADNOR PA 19087 484-586-3513
ACT Capital Management, LLLP (Filed by) CIK: 0001442273 (see all company filings)

IRS No.: 141895400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A